Results 71 to 80 of about 1,677,383 (218)

Assessing the impact of triiodothyronine treatment on the lung microbiome of mice with pulmonary fibrosis

open access: yesBMC Pulmonary Medicine
Background Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease, is characterized by the exacerbation of progressive pulmonary fibrosis (PF). IPF primarily affects older individuals and can lead to respiratory failure.
Xiaoshu Guo   +4 more
doaj   +1 more source

GSR Deficiency Exacerbates Oxidative Stress and Promotes Pulmonary Fibrosis

open access: yesBiomolecules
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disorder characterized by excessive scarring of lung tissue, predominantly affecting middle-aged and elderly populations.
Wenyu Zhao   +10 more
doaj   +1 more source

Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert’s syndrome

open access: yesBMC Pulmonary Medicine
Liver-related side effects are a known complication of treatment with elexacaftor/tezacaftor/ivacaftor (ETI) for cystic fibrosis (CF). Gilbert’s syndrome is caused by a genetic mutation that reduces activity of the enzyme UDP glucuronosyltransferase 1 ...
Julia Weitzel   +4 more
doaj   +1 more source

Validating the Data Completeness and Accuracy of the Canadian Cystic Fibrosis Registry

open access: yesCanadian Respiratory Journal
Conclusion: Our validation of the CCFR demonstrated high accuracy for clinical and demographic variables used in clinical research.
Ranjani Somayaji   +9 more
doaj   +1 more source

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease [PDF]

open access: bronze, 2023
David Zhang   +14 more
openalex   +1 more source

CAMKK2 restored mitochondrial dynamics homeostasis to alleviate pulmonary fibrosis via AMPK/PGC-1α signaling pathway in lung fibroblasts

open access: yesMolecular Medicine
Background Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by aberrant fibroblast activation and extracellular matrix deposition. Emerging evidence implicates mitochondrial dysfunction in IPF pathogenesis.
Yanlin Zhou   +15 more
doaj   +1 more source

Idiopathic pulmonary fibrosis: pathogenesis and management

open access: yesRespiratory Research, 2018
BackgroundIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease characterized by the aberrant accumulation of fibrotic tissue in the lungs parenchyma, associated with significant morbidity and poor prognosis.
G. Sgalla   +5 more
semanticscholar   +1 more source

Triiodothyronine acts on DAO to regulate pulmonary fibrosis progression by facilitating cell senescence through the p53/p21 signaling pathway

open access: yesFrontiers in Pharmacology
BackgroundIdiopathic pulmonary fibrosis (IPF) is the result of multiple cycles of epithelial cell injury and fibroblast activation; currently, there is no clear etiology. Increasing evidence suggests that protein metabolism and amino acids play a crucial
Xiaoshu Guo   +12 more
doaj   +1 more source

Hibiscus manihot L. flower extract induces anticancer activity through modulation of apoptosis and autophagy in A549 cells

open access: yesScientific Reports
Lung cancer is a major public health issue and heavy burden in China and worldwide due to its high incidence and mortality without effective treatment. It’s imperative to develop new treatments to overcome drug resistance.
Minglu Xu   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy